Ignite Creation Date:
2024-05-06 @ 9:30 AM
Last Modification Date:
2024-10-26 @ 12:15 PM
Study NCT ID:
NCT02990845
Status:
TERMINATED
Last Update Posted:
2023-02-22
First Post:
2016-12-01
Brief Title:
Pembrolizumab and Exemestane Leuprolide in Premenopausal HR HER2- Locally Advanced or Metastatic Breast Cancer
Sponsor:
Organization:
National Taiwan University Hospital